Your browser doesn't support javascript.
loading
Thalidomide Therapy on A Case of Prurigo Nodularis
Annals of Dermatology ; : 117-120, 1993.
Article in English | WPRIM | ID: wpr-88353
ABSTRACT
Prurigo nodularis is a troublesome chronic dermatosis that showed unsatisfactory response to conventional therapies. Since thalidomide has been applied to the treatment of prurigo nodularis, although the action mechanism is still uncertain, many dermatologists have confirmed its effectiveness. We treated a 54-year-old male patient who had prurigo nodularis affecting the whole body for 10 years with 100 to 300mg of thalidomide daily as the sole therapy for 4 months. The skin lesions were flattened leaving postinflammatory hyperpigmentation and the pruritus also sub-sided. Two years after stopping thalidomide, no recurrence was observed.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prurigo / Pruritus / Recurrence / Skin / Skin Diseases / Thalidomide / Hyperpigmentation Limits: Humans / Male Language: English Journal: Annals of Dermatology Year: 1993 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prurigo / Pruritus / Recurrence / Skin / Skin Diseases / Thalidomide / Hyperpigmentation Limits: Humans / Male Language: English Journal: Annals of Dermatology Year: 1993 Type: Article